These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18774413)

  • 1. Abacavir and increased risk of myocardial infarction.
    Goicoechea M; McCutchan A
    Lancet; 2008 Sep; 372(9641):803-4; author reply 804-5. PubMed ID: 18774413
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart attack risk with abacavir and didanosine.
    AIDS Patient Care STDS; 2008 Apr; 22(4):346-7. PubMed ID: 18434947
    [No Abstract]   [Full Text] [Related]  

  • 3. Abacavir and the potential risk of myocardial infarction.
    Cutrell A; Brothers C; Yeo J; Hernandez J; Lapierre D
    Lancet; 2008 Apr; 371(9622):1413. PubMed ID: 18387668
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA notifications. Large study suggests heart attack risk from use of abacavir or didanosine.
    AIDS Alert; 2008 May; 23(5):58-9. PubMed ID: 18642404
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.
    ; Sabin CA; Worm SW; Weber R; Reiss P; El-Sadr W; Dabis F; De Wit S; Law M; D'Arminio Monforte A; Friis-Møller N; Kirk O; Pradier C; Weller I; Phillips AN; Lundgren JD
    Lancet; 2008 Apr; 371(9622):1417-26. PubMed ID: 18387667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abacavir, didanosine and tenofovir do not induce inflammatory, apoptotic or oxidative stress genes in coronary endothelial cells.
    Kim C; Gupta SK; Green L; Taylor BM; Deuter-Reinhard M; Desta Z; Clauss M
    Antivir Ther; 2011; 16(8):1335-9. PubMed ID: 22155915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abacavir and increased risk of myocardial infarction.
    Post FA; Campbell LJ
    Lancet; 2008 Sep; 372(9641):803; author reply 804-5. PubMed ID: 18774412
    [No Abstract]   [Full Text] [Related]  

  • 8. Abacavir, Didanosine: myocardial infarction.
    Prescrire Int; 2008 Dec; 17(98):244. PubMed ID: 19431227
    [No Abstract]   [Full Text] [Related]  

  • 9. Abacavir and increased risk of myocardial infarction.
    Edwards R; Bate A; Lindquist M
    Lancet; 2008 Sep; 372(9641):805. PubMed ID: 18774415
    [No Abstract]   [Full Text] [Related]  

  • 10. Abacavir and cardiovascular risk.
    Behrens GM; Reiss P
    Curr Opin Infect Dis; 2010 Feb; 23(1):9-14. PubMed ID: 19996748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.
    Bedimo RJ; Westfall AO; Drechsler H; Vidiella G; Tebas P
    Clin Infect Dis; 2011 Jul; 53(1):84-91. PubMed ID: 21653308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction.
    Francisci D; Falcinelli E; Belfiori B; Petito E; Fierro T; Baldelli F; Gresele P
    AIDS Patient Care STDS; 2011 Oct; 25(10):567-9. PubMed ID: 21851265
    [No Abstract]   [Full Text] [Related]  

  • 13. Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study.
    Obel N; Farkas DK; Kronborg G; Larsen CS; Pedersen G; Riis A; Pedersen C; Gerstoft J; Sørensen HT
    HIV Med; 2010 Feb; 11(2):130-6. PubMed ID: 19682101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients.
    ;
    AIDS; 2008 Sep; 22(14):F17-24. PubMed ID: 18753925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abacavir and didanosine increase the risk of heart attack.
    AIDS Patient Care STDS; 2008 Mar; 22(3):253-4. PubMed ID: 18348343
    [No Abstract]   [Full Text] [Related]  

  • 16. Warning against rechallenge with abacavir.
    AIDS Patient Care STDS; 1998 Mar; 12(3):229. PubMed ID: 11361938
    [No Abstract]   [Full Text] [Related]  

  • 17. Large lymphadenopathies complicating the abacavir hypersensitivity reaction.
    García JT; González PR; Hernández-Mora MG; Novoa SR; Quintana FB; Lahoz JG; Vázquez VS
    AIDS; 2007 Oct; 21(16):2254-6. PubMed ID: 18090059
    [No Abstract]   [Full Text] [Related]  

  • 18. Vertigo and abacavir.
    Fantry LE; Staecker H
    AIDS Patient Care STDS; 2002 Jan; 16(1):5-7. PubMed ID: 11839213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abacavir-induced liver toxicity in an HIV-infected patient.
    Di Filippo E; Ripamonti D; Rizzi M
    AIDS; 2014 Feb; 28(4):613. PubMed ID: 24469001
    [No Abstract]   [Full Text] [Related]  

  • 20. [Non-cirrhotic portal hypertension associated with didanosine: An unusual cause of gastrointestinal bleeding].
    Gómez-Rubio J; Bárcena-Atalaya AB; Macías-García L; Lozano de León-Naranjo F
    Med Clin (Barc); 2015 Jul; 145(1):45. PubMed ID: 25510631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.